Cargando…
Protective Effect of Glucosinolates Hydrolytic Products in Neurodegenerative Diseases (NDDs)
Crucifer vegetables, Brassicaceae and other species of the order Brassicales, e.g., Moringaceae that are commonly consumed as spice and food, have been reported to have potential benefits for the treatment and prevention of several health disorders. Though epidemiologically inconclusive, investigati...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986460/ https://www.ncbi.nlm.nih.gov/pubmed/29738500 http://dx.doi.org/10.3390/nu10050580 |
_version_ | 1783328928452050944 |
---|---|
author | Jaafaru, Mohammed Sani Abd Karim, Nurul Ashikin Enas, Mohamad Eliaser Rollin, Patrick Mazzon, Emanuela Abdull Razis, Ahmad Faizal |
author_facet | Jaafaru, Mohammed Sani Abd Karim, Nurul Ashikin Enas, Mohamad Eliaser Rollin, Patrick Mazzon, Emanuela Abdull Razis, Ahmad Faizal |
author_sort | Jaafaru, Mohammed Sani |
collection | PubMed |
description | Crucifer vegetables, Brassicaceae and other species of the order Brassicales, e.g., Moringaceae that are commonly consumed as spice and food, have been reported to have potential benefits for the treatment and prevention of several health disorders. Though epidemiologically inconclusive, investigations have shown that consumption of those vegetables may result in reducing and preventing the risks associated with neurodegenerative disease development and may also exert other biological protections in humans. The neuroprotective effects of these vegetables have been ascribed to their secondary metabolites, glucosinolates (GLs), and their related hydrolytic products, isothiocyanates (ITCs) that are largely investigated for their various medicinal effects. Extensive pre-clinical studies have revealed more than a few molecular mechanisms of action elucidating multiple biological effects of GLs hydrolytic products. This review summarizes the most significant and up-to-date in vitro and in vivo neuroprotective actions of sulforaphane (SFN), moringin (MG), phenethyl isothiocyanate (PEITC), 6-(methylsulfinyl) hexyl isothiocyanate (6-MSITC) and erucin (ER) in neurodegenerative diseases. |
format | Online Article Text |
id | pubmed-5986460 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-59864602018-06-05 Protective Effect of Glucosinolates Hydrolytic Products in Neurodegenerative Diseases (NDDs) Jaafaru, Mohammed Sani Abd Karim, Nurul Ashikin Enas, Mohamad Eliaser Rollin, Patrick Mazzon, Emanuela Abdull Razis, Ahmad Faizal Nutrients Review Crucifer vegetables, Brassicaceae and other species of the order Brassicales, e.g., Moringaceae that are commonly consumed as spice and food, have been reported to have potential benefits for the treatment and prevention of several health disorders. Though epidemiologically inconclusive, investigations have shown that consumption of those vegetables may result in reducing and preventing the risks associated with neurodegenerative disease development and may also exert other biological protections in humans. The neuroprotective effects of these vegetables have been ascribed to their secondary metabolites, glucosinolates (GLs), and their related hydrolytic products, isothiocyanates (ITCs) that are largely investigated for their various medicinal effects. Extensive pre-clinical studies have revealed more than a few molecular mechanisms of action elucidating multiple biological effects of GLs hydrolytic products. This review summarizes the most significant and up-to-date in vitro and in vivo neuroprotective actions of sulforaphane (SFN), moringin (MG), phenethyl isothiocyanate (PEITC), 6-(methylsulfinyl) hexyl isothiocyanate (6-MSITC) and erucin (ER) in neurodegenerative diseases. MDPI 2018-05-08 /pmc/articles/PMC5986460/ /pubmed/29738500 http://dx.doi.org/10.3390/nu10050580 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Jaafaru, Mohammed Sani Abd Karim, Nurul Ashikin Enas, Mohamad Eliaser Rollin, Patrick Mazzon, Emanuela Abdull Razis, Ahmad Faizal Protective Effect of Glucosinolates Hydrolytic Products in Neurodegenerative Diseases (NDDs) |
title | Protective Effect of Glucosinolates Hydrolytic Products in Neurodegenerative Diseases (NDDs) |
title_full | Protective Effect of Glucosinolates Hydrolytic Products in Neurodegenerative Diseases (NDDs) |
title_fullStr | Protective Effect of Glucosinolates Hydrolytic Products in Neurodegenerative Diseases (NDDs) |
title_full_unstemmed | Protective Effect of Glucosinolates Hydrolytic Products in Neurodegenerative Diseases (NDDs) |
title_short | Protective Effect of Glucosinolates Hydrolytic Products in Neurodegenerative Diseases (NDDs) |
title_sort | protective effect of glucosinolates hydrolytic products in neurodegenerative diseases (ndds) |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986460/ https://www.ncbi.nlm.nih.gov/pubmed/29738500 http://dx.doi.org/10.3390/nu10050580 |
work_keys_str_mv | AT jaafarumohammedsani protectiveeffectofglucosinolateshydrolyticproductsinneurodegenerativediseasesndds AT abdkarimnurulashikin protectiveeffectofglucosinolateshydrolyticproductsinneurodegenerativediseasesndds AT enasmohamadeliaser protectiveeffectofglucosinolateshydrolyticproductsinneurodegenerativediseasesndds AT rollinpatrick protectiveeffectofglucosinolateshydrolyticproductsinneurodegenerativediseasesndds AT mazzonemanuela protectiveeffectofglucosinolateshydrolyticproductsinneurodegenerativediseasesndds AT abdullrazisahmadfaizal protectiveeffectofglucosinolateshydrolyticproductsinneurodegenerativediseasesndds |